doi: 10.3389/fnagi.2014.00041 Biomarker-based diagnosis of mild cognitive impairment due to Alzheimer’s disease: how and what to tell. A kickstart to an ethical discussio
Item does not contain fulltextBACKGROUND: The shift to defining Alzheimer's disease (AD) as a biolog...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder of aging that presents with mem...
Copyright: © 2012 de Mendonça. This is an open-access article distributed under the terms of the Cre...
Biomarker-based diagnosis of mild cognitive impairment due to Alzheimer's disease: how and what...
New criteria for the diagnosis of Alzheimer’s disease (AD) based on biomarker results have recently ...
New criteria for the diagnosis of Alzheimer's disease (AD) based on biomarker results have recently ...
Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in A...
BACKGROUND: Today, many healthcare or dementia organizations, clinicians, and companies emphasize th...
There is great interest in the use of biomarkers to assist in the timely identification of Alzheimer...
See Schott and Petersen for a scientific commentary on this article (doi:10.1093/brain/awv055). Thre...
This article presents recommendations, based on the Grading of Recommendations, Assessment, Developm...
Background: The NIA-AA research framework proposes a purely biological definition of Alzheimer’s dis...
This article presents recommendations, based on the Grading of Recommendations, Assessment, Developm...
Background: Mild cognitive impairment is often a precursor to dementia due to Alzheimer’s disease, b...
Alzheimer's disease (AD) is a kind of central nervous system degenerative disease with higher incide...
Item does not contain fulltextBACKGROUND: The shift to defining Alzheimer's disease (AD) as a biolog...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder of aging that presents with mem...
Copyright: © 2012 de Mendonça. This is an open-access article distributed under the terms of the Cre...
Biomarker-based diagnosis of mild cognitive impairment due to Alzheimer's disease: how and what...
New criteria for the diagnosis of Alzheimer’s disease (AD) based on biomarker results have recently ...
New criteria for the diagnosis of Alzheimer's disease (AD) based on biomarker results have recently ...
Mild cognitive impairment (part 2): biological markers for diagnosis and prediction of dementia in A...
BACKGROUND: Today, many healthcare or dementia organizations, clinicians, and companies emphasize th...
There is great interest in the use of biomarkers to assist in the timely identification of Alzheimer...
See Schott and Petersen for a scientific commentary on this article (doi:10.1093/brain/awv055). Thre...
This article presents recommendations, based on the Grading of Recommendations, Assessment, Developm...
Background: The NIA-AA research framework proposes a purely biological definition of Alzheimer’s dis...
This article presents recommendations, based on the Grading of Recommendations, Assessment, Developm...
Background: Mild cognitive impairment is often a precursor to dementia due to Alzheimer’s disease, b...
Alzheimer's disease (AD) is a kind of central nervous system degenerative disease with higher incide...
Item does not contain fulltextBACKGROUND: The shift to defining Alzheimer's disease (AD) as a biolog...
Alzheimer's disease (AD) is a progressive neurodegenerative disorder of aging that presents with mem...
Copyright: © 2012 de Mendonça. This is an open-access article distributed under the terms of the Cre...
DOI
Add to ORKG